The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer

Recruiting now

Conditions studied: Breast Cancer

In brief

This study investigates plasma metabolites to clarify the relationship between these metabolites and breast cancer, aiming to identify valuable biomarkers. Furthermore, by incorporating clinical information-such as cancer stage, type, treatment outcomes, and prognosis-into prospective studies, the research seeks to further examine the correlation between plasma metabolites, treatment efficacy, and prognosis.

Key facts

Study ID
NCT06698679
Run by
Shengjing Hospital
People needed
1000
Starts
2024-11-15
Expected to finish
2031-10-31
Last updated by the study team
2024-11-21

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.